Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Feb 18 | EXEL | Exelixis, INC. | MEXER◆ | 20,030 | — | — | — | Open the original filing on SEC.gov |
| Feb 18 | EXEL | Exelixis, INC. | MEXER◆ | 44,087 | — | — | — | Open the original filing on SEC.gov |
| Feb 18 | EXEL | Exelixis, INC. | SSELL | 20,030 | $44.30 | $887.3K | -49.3% | Open the original filing on SEC.gov |
| Feb 18 | EXEL | Exelixis, INC. | MEXER | 20,030 | $21.69 | $434.5K | +97.3% | Open the original filing on SEC.gov |
| Feb 18 | EXEL | Exelixis, INC. | SSELL | 44,087 | $44.50 | $2M | -68.2% | Open the original filing on SEC.gov |
| Feb 18 | EXEL | Exelixis, INC. | MEXER | 44,087 | $19.39 | $854.8K | +214.1% | Open the original filing on SEC.gov |
| Feb 17 | EXEL | Exelixis, INC. | MEXER◆ | 42,422 | — | — | — | Open the original filing on SEC.gov |
| Feb 17 | EXEL | Exelixis, INC. | SSELL | 42,422 | $43.33 | $1.8M | -67.3% | Open the original filing on SEC.gov |
| Feb 17 | EXEL | Exelixis, INC. | MEXER | 42,422 | $18.19 | $771.7K | +206.0% | Open the original filing on SEC.gov |
| Jun 3, 2025 | STOK | Stoke Therapeutics, Inc. | AGRANT◆ | 29,747 | — | — | — | Open the original filing on SEC.gov |
| May 29, 2025 | EXEL | Exelixis, INC. | AGRANT | 9,812 | — | — | +91.0% | Open the original filing on SEC.gov |